Source:http://linkedlifedata.com/resource/pubmed/id/17255785
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2007-1-26
|
pubmed:abstractText |
Molecular mutations play an increasing role for classification, prognostication, and therapeutic strategies in acute myeloid leukemia and myelodysplastic syndrome. Due to the rapid expansion of known molecular markers, this paper aims to outline some of the recent progress to improve understanding of the pathogenesis in these myeloid malignancies.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1065-6251
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
14
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
90-7
|
pubmed:meshHeading | |
pubmed:year |
2007
|
pubmed:articleTitle |
Insight into the molecular pathogenesis of myeloid malignancies.
|
pubmed:affiliation |
MLL Munich Leukemia Laboratory, Germany. torsten.haferlach@mll-online.com
|
pubmed:publicationType |
Journal Article,
Review
|